Search - tctmd.com

Displaying 301 - 320 of 383

Sort: Relevancy | Date

Presentation THT 2026

Worsening heart failure and subsequent heart failure events

Presenter: Michael Stanley Kiernan

March 02, 2026

Presentation THT 2026

Management of Acute Decompensated Valvular Heart Disease

Presenter: Jörg Hausleiter

March 02, 2026

Presentation THT 2026

Impella Use for Ventricular Unloading During VA-ECMO Compared With VA-ECMO Alone: An Analysis of the American Heart Association Cardiogenic Shock Registry (AHA-CSR)

Presenter: Rahul Gunukula

March 02, 2026

Presentation THT 2026

How To Treat AHF Before Admission — Device Based Early Identification and Treatment

Presenter: Liviu Klein

March 02, 2026

Presentation THT 2026

The Role of the Heart in HFpEF

Presenter: Javed Butler

March 02, 2026

Presentation THT 2026

What Causes Inflammation in HFpEF? What Lights the Fire?

Presenter: Mark C. Petrie

March 02, 2026

Presentation THT 2026

The Cardio-Hematopoietic Axis in HFpEF: A Theory of Everything

Presenter: Douglas L. Mann

March 02, 2026

Presentation THT 2026

The Adipokine Hypothesis of HFpEF: A New Unifying Framework

Presenter: Milton Packer

March 02, 2026

Presentation THT 2026

Role of Obesity and Adiposity in HFpEF: Fat Is Where It Is At

Presenter: Barry Borlaug

March 02, 2026

Presentation THT 2026

Session Introduction: Identifying the Root Cause of HFpEF

Presenter: Scott Solomon

March 02, 2026

Presentation THT 2026

Barriers and Opportunities Related to the Introduction of Innovation in Durable MCS Devices

Presenter: Kevin Bourque

March 02, 2026

Presentation THT 2026

Durable Mechanical Support: The Next Chapter

Presenter: Mandeep R. Mehra

March 02, 2026

Presentation THT 2026

Xenotransplant: The Journey From the Kidney to the HEART

Presenter: Robert A. Montgomery

March 02, 2026

Presentation THT 2026

Implant-Free Atrial Septal Shunt in a Heart Failure Patient with Reduced Ejection Fraction: A Case Report

Presenter: David Niehaus

March 02, 2026

Presentation THT 2026

Renal Xenotransplant: Early Success and Implications for Patients With ESRD

Presenter: Leonardo Riella

March 02, 2026

Presentation THT 2026

Welcome to THT 2026

Presenter: Daniel Burkhoff

March 02, 2026

Presentation CTO 2026

Paclitaxel or Sirolimus Coated Balloon After Recanalization of Chronic Total Occlusion: A Subanalysis of the PICCOLETO X Multicenter Study

Presenter: Bernardo Cortese

February 14, 2026

Presentation CTO 2026

Artificial‑Intelligence–Derived Quantitative Analyses of Plaque Composition in Patients Undergoing CTO PCI: From PROGRESS‑CTO Registry

Presenter: Pedro Carvalho

February 14, 2026

Presentation CTO 2026

Bioresorbable Scaffolds and Targeted Drug-Delivery in Chronic Total Occlusion Revascularization

Presenter: Nayana Bhandari

February 14, 2026

Presentation CTO 2026

Safety and Feasibility of the Supira System in High Risk Percutaneous Coronary Interventions: 1-Year Single Center Results From the US SUPPORT I EFS

Presenter: Tai Pham

February 14, 2026

Advertisement

Worsening heart failure and subsequent heart failure events

Management of Acute Decompensated Valvular Heart Disease

Impella Use for Ventricular Unloading During VA-ECMO Compared With VA-ECMO Alone: An Analysis of the American Heart Association Cardiogenic Shock Registry (AHA-CSR)

How To Treat AHF Before Admission — Device Based Early Identification and Treatment

The Role of the Heart in HFpEF

What Causes Inflammation in HFpEF? What Lights the Fire?

The Cardio-Hematopoietic Axis in HFpEF: A Theory of Everything

The Adipokine Hypothesis of HFpEF: A New Unifying Framework

Role of Obesity and Adiposity in HFpEF: Fat Is Where It Is At

Session Introduction: Identifying the Root Cause of HFpEF

Barriers and Opportunities Related to the Introduction of Innovation in Durable MCS Devices

Durable Mechanical Support: The Next Chapter

Xenotransplant: The Journey From the Kidney to the HEART

Implant-Free Atrial Septal Shunt in a Heart Failure Patient with Reduced Ejection Fraction: A Case Report

Renal Xenotransplant: Early Success and Implications for Patients With ESRD

Welcome to THT 2026

Paclitaxel or Sirolimus Coated Balloon After Recanalization of Chronic Total Occlusion: A Subanalysis of the PICCOLETO X Multicenter Study

Artificial‑Intelligence–Derived Quantitative Analyses of Plaque Composition in Patients Undergoing CTO PCI: From PROGRESS‑CTO Registry

Bioresorbable Scaffolds and Targeted Drug-Delivery in Chronic Total Occlusion Revascularization

Safety and Feasibility of the Supira System in High Risk Percutaneous Coronary Interventions: 1-Year Single Center Results From the US SUPPORT I EFS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content